User profiles for Cristina Baldoli
cristina baldoliPediatric Neuroradiologist, San Raffaele Scientific Institute Verified email at hsr.it Cited by 4131 |
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy
…, L Lorioli, M Cesani, F Fumagalli, T Plati, C Baldoli… - Science, 2013 - science.org
Introduction Metachromatic leukodystrophy (MLD) is a neurodegenerative lysosomal
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
storage disease caused by arylsulfatase A (ARSA) deficiency. The disease primarily affects …
Neural language networks at birth
…, A Anwander, D Spada, C Baldoli… - Proceedings of the …, 2011 - National Acad Sciences
The ability to learn language is a human trait. In adults and children, brain imaging studies
have shown that auditory language activates a bilateral frontotemporal network with a left …
have shown that auditory language activates a bilateral frontotemporal network with a left …
Functional specializations for music processing in the human newborn brain
…, G Andreolli, R Rovelli, C Baldoli… - Proceedings of the …, 2010 - National Acad Sciences
In adults, specific neural systems with right-hemispheric weighting are necessary to process
pitch, melody, and harmony as well as structure and meaning emerging from musical …
pitch, melody, and harmony as well as structure and meaning emerging from musical …
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
…, L Lorioli, F Fumagalli, S Acquati, D Redaelli, C Baldoli… - The Lancet, 2016 - thelancet.com
Background Metachromatic leukodystrophy (a deficiency of arylsulfatase A [ARSA]) is a fatal
demyelinating lysosomal disease with no approved treatment. We aimed to assess the long-…
demyelinating lysosomal disease with no approved treatment. We aimed to assess the long-…
[HTML][HTML] Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase …
Background Effective treatment for metachromatic leukodystrophy (MLD) remains a substantial
unmet medical need. In this study we investigated the safety and efficacy of atidarsagene …
unmet medical need. In this study we investigated the safety and efficacy of atidarsagene …
[HTML][HTML] Hematopoietic stem-and progenitor-cell gene therapy for Hurler syndrome
Background Allogeneic hematopoietic stem-cell transplantation is the standard of care for
Hurler syndrome (mucopolysaccharidosis type I, Hurler variant [MPSIH]). However, this …
Hurler syndrome (mucopolysaccharidosis type I, Hurler variant [MPSIH]). However, this …
Apparent diffusion coefficient determination in normal fetal brain: a prenatal MR imaging study
…, P Gementi, L Ramenghi, C Baldoli… - American journal …, 2003 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Diffusion-weighted MR imaging studies of normal brain
development have focused on premature babies who were free of focal lesions on …
development have focused on premature babies who were free of focal lesions on …
Terminal zones of myelination: MR evaluation of children aged 20–40 months
C Parazzini, C Baldoli, G Scotti… - American Journal of …, 2002 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: MR imaging is the method of choice for assessment in
vivo of the development of myelination of the human central nervous system. During the first …
vivo of the development of myelination of the human central nervous system. During the first …
[HTML][HTML] A hierarchical procedure to select intrauterine and extrauterine factors for methodological validation of preterm birth risk estimation
Background Etiopathogenesis of preterm birth (PTB) is multifactorial, with a universe of risk
factors interplaying between the mother and the environment. It is of utmost importance to …
factors interplaying between the mother and the environment. It is of utmost importance to …
Metachromatic leukodystrophy: A single‐center longitudinal study of 45 patients
In this study, we characterize the natural course of metachromatic leukodystrophy (MLD),
explore intra/inter group differences, and identify biomarkers to monitor disease progression. …
explore intra/inter group differences, and identify biomarkers to monitor disease progression. …